Moleac.com
  • Home
  • About Us
    • Vision, Values & Mission
    • Milestones
    • Leadership
      • Management Team & Advisors
      • Board of Directors
      • Scientific Advisors & Collaborators
    • Our People, Our Company
    • Responsibility
  • R & D
    • Pipeline
    • Our Strategic Approach
    • Research & Development
    • Publications
  • Products
    • NeuroAiD™II
  • Partners
    • Our Commercial Partners
    • Commercial Partnering Opportunities
    • Research Opportunities
  • News
  • Library
  • Contact Us
  • Career
Select Page
TCM trial for stroke survivors

Mar 8, 2022 | News

Categories

  • Alzheimer News
  • News
  • Stroke News
  • TBI News

Recent Posts

  • Moleac is pleased to announce that NeuroAiD™II has been awarded Gold accreditation by Empowered By Evidence.
  • How to Support a Person with Alzheimer’s Disease?
  • Advancing Post-Stroke Care: Moleac at the J.P. Morgan Healthcare Conference
  • When Does Physical Activity Matter Most for Dementia Risk? Insights from the Framingham Heart Study
  • Caring for a Loved One After a Traumatic Brain Injury (TBI)
Next News

Chinese Herbal Medicine May Have Delayed Benefit in Stroke

→

Quick links

Home
About Us
Contact
Privacy Policy
Terms & Conditions

Find us

Moleac Pte Ltd

Contact

  • Helios #09-08, 11 Biopolis Way, Singapore 138667
  • +65 62113710
  • [email protected]

Connect

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2003-2026. All Rights Reserved. NeuroAiD by Moleac Pte Ltd, Helios #09-08, 11 Biopolis Way, Singapore 138667

loading

Please wait while you are redirected to the right page...